Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. - Wikidata - thesis-toulmin - TriplyDB

Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.

Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.

http://www.wikidata.org/entity/Q30498672

about

Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to United States Food and Drug Administration (FDA) guidelines.Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study Aquapuncture Using Stem Cell Therapy to Treat Mdx Mice.Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes.Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model.Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy.Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9.Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients.Myocardial Contractile Dysfunction Is Present without Histopathology in a Mouse Model of Limb-Girdle Muscular Dystrophy-2F and Is Prevented after Claudin-5 Virotherapy.Evolving diagnostic and prognostic imaging of the various cardiomyopathies.Neuromuscular disorders in zebrafish: state of the art and future perspectives.Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.Transverse tubule remodelling: a cellular pathology driven by both sides of the plasmalemma?Prenatal diagnosis of congenital myopathies and muscular dystrophies.Striated muscle function, regeneration, and repair Symptomatic Trifascicular Block in Steinert's Disease: Is It Too Soon for a Pacemaker?Myotonic Dystrophy Type 1 Management and Therapeutics.Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?Cardiac Involvement Classification and Therapeutic Management in Patients with Duchenne Muscular Dystrophy.Magnetic resonance imaging of myocardial strain: A review of current approaches.Magnetic resonance of the heart in a muscular dystrophy patient with an MR conditional ICD: assessment of safety, diagnostic value and technical limitations Progression of Duchenne Cardiomyopathy Presenting with Chest Pain and Troponin Elevation.Epicardial ablation of ventricular tachycardia in a patient with Becker muscular dystrophy.Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.MicroRNA based treatment of cardiomyopathy: not all dystrophies are created equal.Early myocardial damage assessment in dystrophinopathies using (99)Tc(m)-MIBI gated myocardial perfusion imaging.Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin.Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I.The role of βII spectrin in cardiac health and disease.Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.

P2860

Q27308877-73B11765-B649-4197-A730-3A3B2C28ADA3 Q27331430-D0027A40-878F-4960-9693-D2DD6D287E9F Q34178860-2B4D4CBA-D2E4-480B-B827-B553801E85AE Q34250674-BE479394-B31C-4696-9355-7172B1C2096F Q35181260-12E9AC9A-DFD8-421E-8142-87C02486C07A Q35206123-D094377E-5E46-449C-B05B-3C68E95F1AD2 Q35576188-D6B7E2DD-4B77-4B32-A848-8FA4FFA36E33 Q35649642-54C37290-6089-4C56-AD7C-A73897585937 Q35999436-D25E313E-DFAA-4124-BA0F-C4E2A04DE35E Q36085348-737AB5BB-9485-42BB-A56E-30F59F8CA801 Q36288840-0B8DE583-E29F-474D-B8A7-1585514030FE Q36356925-59E049A5-4FD6-4E74-9BF2-75356FFF15E9 Q36817631-0CE615EF-ED4B-4421-BCC8-550070BAA084 Q36875975-37FCD738-84B3-48E0-B6E3-B104C26F2D28 Q36918560-3F20DE6B-1F60-48E1-89E2-086C652E6A07 Q37364419-ACB760E6-747B-43F0-B50E-E9E78D8A3052 Q37474934-3A8D2D43-FDAA-4671-9A71-5F2C9FCAA310 Q38006744-31E59D83-BF15-4E47-90C8-D03D49396C62 Q38098929-B1F9BCEC-AFBF-4C7B-92BF-614746555C59 Q38640186-B7C71357-DE06-42D6-A3F0-6D8286330634 Q38684811-07E5E3CF-B21D-4F62-865E-B82C825A75B7 Q38838661-2AE1770B-5E92-4947-B780-6AF14962F41A Q38857890-DE32643F-96BD-47A1-BBA8-181F4AF51EBC Q38955528-94683447-B1E6-4AB2-BB72-7730A689CF03 Q39003493-BBFB76D1-40D4-4E46-8D66-81C004149273 Q39010745-4B0C21EE-F9D7-42C9-9CB4-5C84BE0ABF5E Q39166732-9FD7DFB2-3466-4979-9A4D-92C3CC32D8D1 Q39283262-5CF10BA2-DED4-49E4-9DB6-43B7B78AB4FE Q39403652-38BCC547-6E09-436D-94B0-CE1DD82BB5EB Q41922953-7D381BFB-0446-4F5E-AAB7-DBCD1400F2E5 Q42071610-F84195A0-122B-4193-8CF7-22BDE8AA3082 Q42275401-D523EDA6-F47E-4619-80E7-346AFF8B75EB Q42855263-0D7B9D2D-921E-45B1-A623-F59CE6437788 Q42906190-65BE00D9-7A44-4D01-9204-B8D1DE51360E Q43131882-1A211A0F-2557-4175-8826-8DF8DCA7AB12 Q44232941-DF794527-D423-471C-BA7C-B8877C6E9C00 Q45384428-7EF78184-4027-4345-A83B-9AA4220116BA Q46263328-F9CE24FF-2684-495F-9BA6-4B3F4AD1C602 Q47325217-25C33340-B651-4F41-AD3E-DC264A526DCF Q48669653-83F64DCB-1C73-4E08-B1E7-85FFF483A031

P2860

Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.

http://www.wikidata.org/entity/Q30498672

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cardiac involvement in patient ...... and genotypic considerations.

@ast

Cardiac involvement in patient ...... and genotypic considerations.

@en

type

label

Cardiac involvement in patient ...... and genotypic considerations.

@ast

Cardiac involvement in patient ...... and genotypic considerations.

@en

prefLabel

Cardiac involvement in patient ...... and genotypic considerations.

@ast

Cardiac involvement in patient ...... and genotypic considerations.

@en

P1433

Q30498672-C54B2F7E-1DE5-43D6-932C-E023056242C4

P1476

Q30498672-B2620C48-D630-4C05-98C3-D546F68D0F98

P2093

Q30498672-2E55BB90-B58C-44D9-B555-EAAC3B1EF2E5

Q30498672-3648E7F6-A503-4614-AC0E-252F54D9D1B4

Q30498672-A05CAB99-CCCC-4BC8-9A11-14626367DA98

Q30498672-AAA74DB2-0614-46E0-8414-8CADA55A241D

P2860

Q30498672-05ADB119-C7AB-40DF-B2EC-B4FED3482664

Q30498672-0B1913FD-D55B-4DCA-98E0-054B59ADF39B

Q30498672-10D6367F-0373-493D-8C51-42C9D4981809

Q30498672-1683A853-644E-4EDA-9AD3-9DD594A17496

Q30498672-19314C26-029A-4972-B978-7AF03936DF06

Q30498672-19CA3E48-0329-4770-8EB8-6EF2D2F45C60

Q30498672-20376501-5942-4C68-BCFD-A11B5ABA5737

Q30498672-267F50A2-3E77-4A7B-AE93-873373BADA5F

Q30498672-28AA1BF4-440F-4A77-9ED5-B992F571833E

Q30498672-3C20DA36-5B8B-4E33-92CF-CDAA6533E15C

P304

Q30498672-347109CA-745B-4B58-AA11-9E6DCE7C56C3

P31

Q30498672-3F3F3520-82A1-452D-A0CE-B5EEB45E896F

P356

Q30498672-DBC403D0-7CC5-403A-8BA6-1DDAB6958C89

P433

Q30498672-72E4DB34-90F3-42F7-8D8D-61EFF69DE3C5

P478

Q30498672-2B4C004E-646B-47EB-84B8-8C45A70DAE8D

P577

Q30498672-97E88827-43A4-4D21-BBBA-7806509DF823

P698

Q30498672-082EF451-1D5F-4E5D-AD27-783A63DCF45D

P932

Q30498672-7A7C052B-512D-447B-B2D3-EC5280FAA6EE

P356

CIRCIMAGING.110.960740

P1433

Circulation: Cardiovascular Imaging

P1476

Cardiac involvement in patient ...... and genotypic considerations.

@en

P2093

David Verhaert

http://www.w3.org/2001/XMLSchema#string

Jill A Rafael-Fortney

http://www.w3.org/2001/XMLSchema#string

Kathryn Richards

http://www.w3.org/2001/XMLSchema#string

Subha V Raman

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy

Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease

Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)

Life at the edge: the nuclear envelope and human disease

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance.

Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.

Joint estimation of water/fat images and field inhomogeneity map.

P304

67-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCIMAGING.110.960740

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21245364

http://www.w3.org/2001/XMLSchema#string

P932

3057042

http://www.w3.org/2001/XMLSchema#string